Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors

被引:46
作者
Justo, D
Prokhorov, V
Heller, K
Zeltser, D
机构
[1] Tel Aviv Sourasky Med Ctr, Dept Internal Med D, Tel Aviv, Israel
[2] Tel Aviv Sourasky Med Ctr, Dept Cardiol, Tel Aviv, Israel
[3] Tel Aviv Sourasky Med Ctr, Dept Emergency Med, Tel Aviv, Israel
关键词
antidepressant; antipsychotic; QT interval; torsade de pointes;
D O I
10.1111/j.1600-0447.2004.00469.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To investigate all published case reports of torsade de pointes (TdP) induced by psychotropic drugs (PDs) in order to examine the prevalence of risk factors for TdP prior to the drug initiation. Method: We found 45 reports on 70 patients with TdP induced by PDs. Each report was analyzed for the presence of risk factors for TdP: female gender, heart disease, hypokalemia, high doses of offending agent, concomitant use of a QT interval prolonging agent, and a history of long-QT syndrome. Results: Female gender was the most common risk factor for TdP (71.4%). The other studied risk factors were also frequently present (34.2-14.2%). Nearly all patients had at least one and 51 (73%) patients had >2 risk factors for TdP prior to PD initiation. Conclusion: We wish to raise the level of awareness of risk factors for TdP in the psychiatric community.
引用
收藏
页码:171 / 176
页数:6
相关论文
共 85 条
[41]   HALOPERIDOL-INDUCED TORSADES-DE-POINTES [J].
KRIWISKY, M ;
PERRY, GY ;
TARCHITSKY, D ;
GUTMAN, Y ;
KISHON, Y .
CHEST, 1990, 98 (02) :482-484
[42]  
LEITERSDORF E, 1982, INT J PSYCHIAT MED, V12, P85
[43]   QT prolongation and torsade de pointes tachycardia with maprotiline:: a note of caution [J].
Lentini, S ;
Rao, ML ;
Schröder, R ;
Lüderitz, B ;
Bauriedel, G .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (49) :1396-1400
[44]   DETAILED ANALYSIS OF 24 HOUR AMBULATORY ELECTROCARDIOGRAPHIC RECORDINGS DURING VENTRICULAR-FIBRILLATION OR TORSADE DE POINTES [J].
LEWIS, BH ;
ANTMAN, EM ;
GRABOYS, TB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 2 (03) :426-436
[45]  
LIBERATORE MA, 1984, J CLIN PSYCHOPHARM, V4, P143
[46]   ELECTROPHYSIOLOGIC STUDIES OF PERPHENAZINE AND PROTRIPTYLINE IN A PATIENT WITH PSYCHOTROPIC DRUG-INDUCED VENTRICULAR-FIBRILLATION [J].
MAGORIEN, RD ;
JEWELL, GM ;
SCHAAL, SF ;
LEIER, CV .
AMERICAN JOURNAL OF MEDICINE, 1979, 67 (02) :353-357
[47]   FEMALE GENDER AS A RISK FACTOR FOR TORSADES-DE-POINTES ASSOCIATED WITH CARDIOVASCULAR DRUGS [J].
MAKKAR, RR ;
FROMM, BS ;
STEINMAN, RT ;
MEISSNER, MD ;
LEHMANN, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (21) :2590-2597
[48]   A child with cardiac arrhythmia and convulsions [J].
Manikoth, P ;
Subramanyan, R ;
Menon, S ;
Al Khusaiby, SM .
LANCET, 1999, 354 (9195) :2046-2046
[49]   QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination [J].
Mazur, A ;
Strasberg, B ;
Kusniec, J ;
Sclarovsky, S .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1995, 52 (01) :27-29
[50]  
METZGER E, 1993, J CLIN PSYCHOPHARM, V13, P128